Cite
Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.
MLA
Yeh, Steven, et al. “Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.” Ophthalmology, vol. 127, no. 7, July 2020, pp. 948–55. EBSCOhost, https://doi.org/10.1016/j.ophtha.2020.01.006.
APA
Yeh, S., Khurana, R. N., Shah, M., Henry, C. R., Wang, R. C., Kissner, J. M., Ciulla, T. A., & Noronha, G. (2020). Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial. Ophthalmology, 127(7), 948–955. https://doi.org/10.1016/j.ophtha.2020.01.006
Chicago
Yeh, Steven, Rahul N. Khurana, Milan Shah, Christopher R. Henry, Robert C. Wang, Jennifer M. Kissner, Thomas A. Ciulla, and Glenn Noronha. 2020. “Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.” Ophthalmology 127 (7): 948–55. doi:10.1016/j.ophtha.2020.01.006.